Rigel Pharmaceuticals reported $115.61M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agenus AGEN:US USD 429.02M 27.15M
Amgen AMGN:US USD 65.12B 1.42B
Anika Therapeutics ANIK:US USD 347.75M 6.38M
Arrowhead Research ARWR:US USD 691.94M 59.84M
Astrazeneca AZN:US USD 94.18B 2.39B
AstraZeneca AZN:LN USD 94.18B 2.39B
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Celldex Therapeutics CLDX:US USD 369.23M 33.74M
Daiichi Sankyo 4568:JP JPY 2.4T 29.74B
Eli Lilly And LLY:US USD 47.46B 397.9M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Immunogen IMGN:US USD 358.8M 63.5M
Intrexon XON:US USD 259.24M 61.98M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Ligand Pharmaceuticals LGND:US USD 1.05B 25.68M
Macrogenics MGNX:US USD 195.35M 22.7M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Veracyte VCYT:US USD 1.13B 18.24M